Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianfeng Han

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 28, 2016
[Comparison of international Ebola virus testing laboratories in Ebola virus disease outbreak in Sierra Leone]Tao Jiang, Guangyu Zhao, Jianfeng Han, et al.
ACS Nano|May 26, 2016
Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia ActivityShuting Zhao, Lingling Zhang, Jianfeng Han, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 29, 2025
Significance of occlusion site on outcomes in stroke patients with large infarction undergoing endovascular therapy: A prespecified subgroup analysis of the ANGEL-ASPECT trialKangyue Li, Dapeng Sun, Mengxing Wang, et al.
Science China. Life Sciences|October 12, 2017
Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic waveYongqiang Deng, Chunlin Li, Jianfeng Han, et al.
Nature Biotechnology|January 4, 2019
Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastomaBo Xu, Rui Ma, Luke Russell, et al.
Nature Biotechnology|November 27, 2018
An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastomaBo Xu, Rui Ma, Luke Russell, et al.
Cancer Research|December 4, 2015
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune ResponseJianfeng Han, Xilin Chen, Jianhong Chu, et al.
The Lancet Regional Health. Western Pacific|December 12, 2022
Prevalence of stroke in China, 2013-2019: A population-based studyWen-Jun Tu, Yang Hua, Feng Yan, et al.
CNS Neuroscience & Therapeutics|December 10, 2025
Perfusion and Structural Impairment in Minor Stroke and Transient Ischemic Attack With Intracranial Atherosclerotic Stenosis: Associations With Cognitive DeclineMeiling Shang, Gezhi Yan, Wanghuan Dun, et al.
Molecular Cancer Therapeutics|December 17, 2016
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse ModelKun-Yu Teng, Jianfeng Han, Xiaoli Zhang, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|January 28, 2016
[Comparison of international Ebola virus testing laboratories in Ebola virus disease outbreak in Sierra Leone]Tao Jiang, Guangyu Zhao, Jianfeng Han, et al.
ACS Nano|May 26, 2016
Conformal Nanoencapsulation of Allogeneic T Cells Mitigates Graft-versus-Host Disease and Retains Graft-versus-Leukemia ActivityShuting Zhao, Lingling Zhang, Jianfeng Han, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 29, 2025
Significance of occlusion site on outcomes in stroke patients with large infarction undergoing endovascular therapy: A prespecified subgroup analysis of the ANGEL-ASPECT trialKangyue Li, Dapeng Sun, Mengxing Wang, et al.
Science China. Life Sciences|October 12, 2017
Phylogenetic and genetic characterization of a 2017 clinical isolate of H7N9 virus in Guangzhou, China during the fifth epidemic waveYongqiang Deng, Chunlin Li, Jianfeng Han, et al.
Nature Biotechnology|January 4, 2019
Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastomaBo Xu, Rui Ma, Luke Russell, et al.
Nature Biotechnology|November 27, 2018
An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastomaBo Xu, Rui Ma, Luke Russell, et al.
Cancer Research|December 4, 2015
TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune ResponseJianfeng Han, Xilin Chen, Jianhong Chu, et al.
The Lancet Regional Health. Western Pacific|December 12, 2022
Prevalence of stroke in China, 2013-2019: A population-based studyWen-Jun Tu, Yang Hua, Feng Yan, et al.
CNS Neuroscience & Therapeutics|December 10, 2025
Perfusion and Structural Impairment in Minor Stroke and Transient Ischemic Attack With Intracranial Atherosclerotic Stenosis: Associations With Cognitive DeclineMeiling Shang, Gezhi Yan, Wanghuan Dun, et al.
Molecular Cancer Therapeutics|December 17, 2016
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse ModelKun-Yu Teng, Jianfeng Han, Xiaoli Zhang, et al.
Pageof 7